Phase III Clinical Trial of rhTNK-tPA in Treating Acute Ischemic Stroke With Extended Time Window.

Abroad (travel likely)RecruitingPHASE3

Conditions

Acute Ischemic Stroke

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Puyang Oilfield General Hospital, Puyang, Henan, China
Contact: Study coordinator (Yutie Zhao, Chief Physician) · 454981103@qq.com · 13633935069

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

rhTNK-tPA for Acute Ischemic Stroke Under Simplified Imaging in the Extended Time Window

Acute Ischemic Stroke

Abroad (travel likely)RecruitingPHASE3

Guangzhou, China

Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)

Acute Stroke · Ischemic Stroke · Stroke

Abroad (travel likely)RecruitingPHASE2, PHASE3

Fairhope, United States · Arcadia, United States

Early Administration of Tirofiban in Patients Treated With Tenecteplase for Acute Ischemic Stroke

Acute Ischemic Stroke

Abroad (travel likely)RecruitingPHASE3

Chuzhou, China · Longyan, China

Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke

Acute Ischemic Stroke · Cerebral Stroke

Abroad (travel likely)RecruitingPHASE3

Tucson, United States · Carmichael, United States